Dr. Reddy's Laboratories Ltd Common Stock vs iShares Silver Trust — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B), while iShares Silver Trust trades at $51.08 (market cap $29.73B). The key difference: iShares Silver Trust is far larger — about 2.8× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while iShares Silver Trust pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and iShares Silver Trust for 90 Days on average.
| RDY | SLV | |
|---|---|---|
Market Cap | $10.78B | $29.73B |
Volume | 2,724,343 | 17,545,887 |
Sector | Health | — |
52-Week High | $15.38 | $105.57 |
52-Week Low | $11.38 | $42.40 |
Typical Hold Time | 0 Days | 90 Days |
Enterprise Value | $10.68B | — |
Dividend Yield | 0.65% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SLV, the iShares Silver Trust ETF, is trading at $50.22, down 7.6% over 24 hours amid a bearish technical signal. The trust holds substantial assets of $13.41 billion with minimal liabilities, but financial metrics like P/E and revenue are unavailable. Recent news highlights pressure from rising Treasury yields and a stronger dollar, contributing to silver's sharp decline.
The outlook remains cautious due to macroeconomic headwinds and Fed policy uncertainty. While silver's industrial and monetary appeal offers long-term potential, near-term volatility and bearish technical indicators suggest limited upside. Risks include interest rate sensitivity and market sentiment shifts, requiring careful monitoring for entry points.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →The ETF seeks to reflect such performance before payment of the ETF's expenses and liabilities. It is not actively managed. The ETF does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of silver.
Read more on SLV →